Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edina, Karai"'
Autor:
Valéria Dékay, Edina Karai, András Füredi, Kornélia Szebényi, Gergely Szakács, Péter Vajdovich
Publikováno v:
Cancers; Volume 14; Issue 16; Pages: 3919
Various mechanisms are known to be involved in the development of multidrug resistance during cancer treatment. P-glycoprotein (P-gp) decreases the intracellular concentrations of cytotoxic drugs by an energy-dependent efflux mechanism. The aim of th
Autor:
Flóra, Vajda, Eszter, Bajtai, Balázs, Gombos, Edina, Karai, Lilla, Hámori, Gergely, Szakács, András, Füredi
Publikováno v:
Magyar onkologia. 65(2)
There are about 14 million new cancer cases and 8 million deaths every year. Every second man and one in every three women will get cancer during their lifetimes. Following decades of steady increase, death rates have stabilized due to increased awar
Autor:
Péter Vajdovich, Kornélia Szebényi, Eszter Szendi, Gergely Szakács, Tímea Windt, Valéria Dékay, Sára Fehér, András Füredi, Edina Karai
Publikováno v:
Cancers, Vol 12, Iss 1117, p 1117 (2020)
Cancers
Volume 12
Issue 5
Cancers
Volume 12
Issue 5
Background: Treatment of malignancies is still a major challenge in human and canine cancer, mostly due to the emergence of multidrug resistance (MDR). One of the main contributors of MDR is the overexpression P-glycoprotein (Pgp), which recognizes a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Magyar Állatorvosok Lapja; Feb2022, Vol. 144 Issue 2, p77-90, 14p
Autor:
FLÓRA, VAJDA, ESZTER, BAJTAI, BALÁZS, GOMBOS, EDINA, KARAI, LILLA, HÁMORI, GERGELY, SZAKÁCS, ANDRÁS, FÜREDI
Publikováno v:
Magyar Onkologia; 2021, Vol. 65 Issue 2, p176-187, 12p
Autor:
József Tóvári, Lilla Hámori, Mihály Cserepes, Gergely Szakács, Kornélia Szebényi, Pál Szabó, Péter Vajdovich, András Füredi, Veronika Nagy, Edina Karai, Szilárd Tóth, Tímea Imre, Dávid Szüts
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 261
Success of cancer treatment is often hampered by the emergence of multidrug resistance (MDR) mediated by P-glycoprotein (ABCB1/Pgp). Doxorubicin (DOX) is recognized by Pgp and therefore it can induce therapy resistance in breast cancer patients. In t
Publikováno v:
Magyar Állatorvosok Lapja; Sep2020, Vol. 142 Issue 9, p531-544, 14p